 Neurometrix Inc. NASDAQ:NURO shares flew higher Tuesday and Wednesday on continued momentum after the company announced its Quell device received Breakthrough Designation from the FDA for treating the symptoms of fibromyalgia in adults. The stock was trending throughout the day on social media sites such as StockTwits. 